{"title":"加拿大医学院院长的利益冲突：一项横断面研究。","authors":"Joel Lexchin","doi":"10.12927/hcpol.2024.27349","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Medical school deans wield considerable influence over research, clinical and educational missions at their institutions. This study investigates conflict of interest (COI) of Canadian medical school deans.</p><p><strong>Method: </strong>The websites of all 17 Canadian medical schools were searched for any mention of relationships between deans and pharmaceutical or medical device companies.</p><p><strong>Results: </strong>No COIs were discovered for 11 of the deans. Six had COIs, including participating in research funded by pharmaceutical companies and received consulting and speaker fees.</p><p><strong>Discussion: </strong>A minority of deans had COIs with healthcare industry companies. Whether deans' COIs affect policies at the medical schools they lead should be the subject of further investigation.</p>","PeriodicalId":39389,"journal":{"name":"Healthcare Policy","volume":"19 4","pages":"70-80"},"PeriodicalIF":0.0000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11411646/pdf/","citationCount":"0","resultStr":"{\"title\":\"Conflicts of Interest of Canadian Medical School Deans: A Cross-Sectional Study.\",\"authors\":\"Joel Lexchin\",\"doi\":\"10.12927/hcpol.2024.27349\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Medical school deans wield considerable influence over research, clinical and educational missions at their institutions. This study investigates conflict of interest (COI) of Canadian medical school deans.</p><p><strong>Method: </strong>The websites of all 17 Canadian medical schools were searched for any mention of relationships between deans and pharmaceutical or medical device companies.</p><p><strong>Results: </strong>No COIs were discovered for 11 of the deans. Six had COIs, including participating in research funded by pharmaceutical companies and received consulting and speaker fees.</p><p><strong>Discussion: </strong>A minority of deans had COIs with healthcare industry companies. Whether deans' COIs affect policies at the medical schools they lead should be the subject of further investigation.</p>\",\"PeriodicalId\":39389,\"journal\":{\"name\":\"Healthcare Policy\",\"volume\":\"19 4\",\"pages\":\"70-80\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11411646/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Healthcare Policy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12927/hcpol.2024.27349\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Healthcare Policy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12927/hcpol.2024.27349","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
摘要
背景：医学院院长对其所在院校的研究、临床和教育任务具有相当大的影响力。本研究调查了加拿大医学院院长的利益冲突（COI）：方法：对加拿大所有 17 所医学院的网站进行了搜索，以查找院长与制药或医疗器械公司之间的关系：结果：11 位院长未发现与制药或医疗器械公司有任何 COI 关系。6位院长有COI，包括参与制药公司资助的研究，以及收取咨询费和演讲费：讨论：少数院长与医疗保健行业公司有利益冲突。院长的 COI 是否会影响其所领导的医学院的政策，应该是进一步调查的主题。
Conflicts of Interest of Canadian Medical School Deans: A Cross-Sectional Study.
Background: Medical school deans wield considerable influence over research, clinical and educational missions at their institutions. This study investigates conflict of interest (COI) of Canadian medical school deans.
Method: The websites of all 17 Canadian medical schools were searched for any mention of relationships between deans and pharmaceutical or medical device companies.
Results: No COIs were discovered for 11 of the deans. Six had COIs, including participating in research funded by pharmaceutical companies and received consulting and speaker fees.
Discussion: A minority of deans had COIs with healthcare industry companies. Whether deans' COIs affect policies at the medical schools they lead should be the subject of further investigation.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
